News
Hosted on MSN16d
Redburn Atlantic Initiates Coverage of Quest Diagnostics (DGX) with Buy RecommendationAnalyst Price Forecast Suggests 7.56% Upside As of March 19, 2025, the average one-year price target for Quest Diagnostics is $182.07/share. The forecasts range from a low of $161.60 to a high of ...
The analysis of recent analyst actions sheds light on the perception of Quest Diagnostics by financial experts. The following summary presents key analysts, their recent evaluations, and ...
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in ... See the top stocks recommended by analysts >> Quest Diagnostics (DGX) Truist Financial analyst David S ...
Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...
Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE ... and includes fundamentals, analyst reports, ownership data and fund sentiment, options ...
Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (LSE ... and includes fundamentals, analyst reports, ownership data and fund sentiment, options ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results